These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 21800005)

  • 1. Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles.
    Lima LG; Oliveira AS; Campos LC; Bonamino M; Chammas R; Werneck C; Vicente CP; Barcinski MA; Petersen LC; Monteiro RQ
    Thromb Haemost; 2011 Oct; 106(4):712-23. PubMed ID: 21800005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvesicles as risk markers for venous thrombosis.
    Rautou PE; Mackman N
    Expert Rev Hematol; 2013 Feb; 6(1):91-101. PubMed ID: 23373784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines.
    Kirszberg C; Lima LG; Da Silva de Oliveira A; Pickering W; Gray E; Barrowcliffe TW; Rumjanek VM; Monteiro RQ
    Melanoma Res; 2009 Oct; 19(5):301-8. PubMed ID: 19550359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intercellular transfer of tissue factor via the uptake of tumor-derived microvesicles.
    Lima LG; Leal AC; Vargas G; Porto-Carreiro I; Monteiro RQ
    Thromb Res; 2013 Oct; 132(4):450-6. PubMed ID: 23993901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state.
    Gheldof D; Mullier F; Bailly N; Devalet B; Dogné JM; Chatelain B; Chatelain C
    Thromb Res; 2014 Mar; 133(3):433-9. PubMed ID: 24290525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.
    Hisada Y; Ay C; Auriemma AC; Cooley BC; Mackman N
    J Thromb Haemost; 2017 Nov; 15(11):2208-2217. PubMed ID: 28834179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of antisense tyrosinase-related protein 1 on melanocytes and malignant melanoma cells.
    Li CY; Gao TW; Wang G; Han ZY; Shen Z; Li TH; Liu YF
    Br J Dermatol; 2004 Jun; 150(6):1081-90. PubMed ID: 15214892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner.
    Lima LG; Chammas R; Monteiro RQ; Moreira ME; Barcinski MA
    Cancer Lett; 2009 Oct; 283(2):168-75. PubMed ID: 19401262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the tissue factor pathway in the biology of tumor initiating cells.
    Garnier D; Milsom C; Magnus N; Meehan B; Weitz J; Yu J; Rak J
    Thromb Res; 2010 Apr; 125 Suppl 2():S44-50. PubMed ID: 20434004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strenuous exercise promotes shear-induced thrombin generation by increasing the shedding of procoagulant microparticles from platelets.
    Chen YW; Chen JK; Wang JS
    Thromb Haemost; 2010 Aug; 104(2):293-301. PubMed ID: 20589321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
    Petersson S; Shubbar E; Enerbäck L; Enerbäck C
    Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer procoagulant (CP) analysis in human WM 115 malignant melanoma cells in vitro.
    Kaplinska K; Rozalski M; Krajewska U; Mielicki WP
    Thromb Res; 2009 Jul; 124(3):364-7. PubMed ID: 19419757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake.
    Lopez-Vilchez I; Diaz-Ricart M; White JG; Escolar G; Galan AM
    Cardiovasc Res; 2009 Nov; 84(2):309-16. PubMed ID: 19541671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles.
    Muhsin-Sharafaldine MR; Saunderson SC; Dunn AC; Faed JM; Kleffmann T; McLellan AD
    Oncotarget; 2016 Aug; 7(35):56279-56294. PubMed ID: 27462921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue Factor Prothrombotic Activity Is Regulated by Integrin-arf6 Trafficking.
    Rothmeier AS; Marchese P; Langer F; Kamikubo Y; Schaffner F; Cantor J; Ginsberg MH; Ruggeri ZM; Ruf W
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1323-1331. PubMed ID: 28495929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filamin-A is required for the incorporation of tissue factor into cell-derived microvesicles.
    Collier ME; Maraveyas A; Ettelaie C
    Thromb Haemost; 2014 Apr; 111(4):647-55. PubMed ID: 24258684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of procoagulant microparticles and properties.
    Freyssinet JM; Toti F
    Thromb Res; 2010 Apr; 125 Suppl 1():S46-8. PubMed ID: 20153515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide induces procoagulant activity through phosphatidylserine exposure and microparticle generation in endothelial cells.
    Zhou J; Li H; Fu Y; Shi J; Hou J; Zhang Y; Liu X; Song P
    Thromb Res; 2011 May; 127(5):466-72. PubMed ID: 21272920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles.
    Muhsin-Sharafaldine MR; Kennedy BR; Saunderson SC; Buchanan CR; Dunn AC; Faed JM; McLellan AD
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):286-295. PubMed ID: 27864149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.